key: cord-1041426-u30a6jiu
authors: Shaik, Fareeda Begum; Swarnalatha, K.; Mohan, M.Chandra; Thomas, Anu; Chikati, Rajasekhar; Sandeep, G.; Maddu, Narendra
title: Novel antiviral effects of chloroquine, hydroxychloroquine, and green tea catechins against SARS-CoV-2 main protease and 3C-like protease for COVID-19 treatment
date: 2022-01-28
journal: Clin Nutr Open Sci
DOI: 10.1016/j.nutos.2021.12.004
sha: 4dc50fed48b2ec1be44a395fc1ea4991eba66e06
doc_id: 1041426
cord_uid: u30a6jiu

Objectives Coronaviruses are globally emerging viruses that threaten our health care systems and have become a popular pandemic around the world. This causes a sudden rise in positive coronavirus cases and related deaths to occur worldwide, representing a significant health hazard to humans and the economy Methods We examined predominantly catechins of green tea include epigallocatechin-3-gallate (EGCG), epicatechin-3-gallate (ECG), and drugs of chloroquine (CQ), and hydroxychloroquine (HCQ) appearing to reveal anti-viral activities. Data were collected from PubMed, Google Scholar, and Science Direct databases. To investigate the role of antiviral effects (CQ and HCQ), green tea catechins, beneficial use of convalescent plasma; covaxin in COVID-19 patients faced a dangerous healthiness issue. Computational docking analysis has been used for this purpose Results The lead compounds are EGCG and ECG act as potential inhibitors bind to the active site region of the HKU4-CoV 3CL protease and M-Pro protease enzymes of coronavirus. Conclusions: SARS-COV-2 is a pathogen of substantial vigour concern and the review unveils the role of catechins associated with many viral diseases. We suggested that the function of green tea catechins, novel drugs of CQ, and HCQ exhibit antiviral activities against positive-sense single-stranded RNA viruses (CoVs).

Coronavirus is also called COronaVIrus Disease of 2019 (COVID-19) first emerged in Wuhan; China in December 2019, and has attracted greater attention and continued to spread throughout the world. Coronaviruses (CoVs) are single-stranded RNA viruses responsible for severe respiratory risks of sudden deaths among older people because of its extensive genetic diversity, short generation time, high mutation rate, homologous RNA recombination, and large genomes [1] . Several studies have shown that coronavirus plays a crucial role in the pathogenesis of respiratory infection and is officially named Severe Acute Respiratory Syndrome CoronaVirus 2 (SARS-CoV-2). It affects the explosion of diverse deaths and currently, there is no specific effective antiviral treatment for COVID-19 [2, 3] .

COVID-19 acts as a prime mediator of the unexpected rise in mortality rates. Public strength and medicinal precautions are mandatory to ensure the control of the spreading of the respiratory infections urgently needed to have timely treatments for the COVID-19 [4] . The World Health Organization (WHO) on March 11, 2020, declared the novel COVID-19 epidemic a global pandemic and is a key player in the promotion of severe respiratory syndrome [5] . Systematic analysis of recent reports documented a strong correlation between the three highly transmissible pathogens like SARS-CoV, MERS-CoV, and SARS-CoV-2 and respiratory illness in humans [6] .

COVID-19 was found to be expressed by symptoms such as fever, sore throat, lesions in the lungs, difficulty in breathing, dry cough, lymphopenia, fatigue, anorexia, arrhythmia, and shock. These symptoms depend on the person's immune system and on its potential role in virulence [7] . Coronaviruses belong to the family Coronaviridae and can be classified into four genera: Alpha-coronavirus, Beta-coronavirus, Gamma-coronavirus, and Deltacoronavirus [8] . Due to the lack of proofreading capacity of RNA polymerase, the coronavirus genome undergoes extensive mutation potential which is relevant to the potential enhancement of the pathogenesis of corona virus infection [9] . Previous observations have shown that coronavirus emerged as an attractive possibility for developing acute respiratory tract infections of pneumonia among humans and contributed to improving virulence towards J o u r n a l P r e -p r o o f morbidity and mortality [10] . Currently, six human coronaviruses (HCoV) have broadly classified into human coronavirus 229E (HCoV-229E), OC43 (HCoV-OC43), NL63 (HCoV-NL63), HKU1 (HCoV-HKU1), severe acute respiratory syndrome (SARS) coronavirus (SARS-CoV), and Middle East respiratory syndrome (MERS) coronavirus (MERS-CoV) [11] . Coronavirus consists of nucleoprotein capsid, envelope, spike, and membrane proteins can be a significant prospect for humans [12] . Currently, Indian Council of Medical Research recommended that hydroxychloroquine are widely used for the treatment of coronavirus infections [13] . CQ and HCQ are the relevant antiviral drugs for the reducing chance of COVID-19 through increased endosomal pH and interference with glycosylation of the angiotensin-converting enzyme 2 (ACE2) receptor [14] . Earlier reports suggested that hydroxychloroquine use was not associated with mortality in COVID-19 patient's results from a randomized controlled trail [15] . Cumulative evidence has indicated that convalescent plasma played a crucial role in the reduction of COVID-19 probability in humans [16] . A prior study showed that reverse-transcriptase polymerase chain reactions (RT-PCRs) are J o u r n a l P r e -p r o o f diagnostic tests for COVID-19 infected patients [17] . Early diagnosis, accurate preventive measures, and social distancing strategies may be sufficient, accurate to control the COVID-19 pandemic [18] . The enzyme RNA-dependent RNA polymerases (RdRPs) revealed more significant markers for the development of drugs in COVID-19 [19] .

Polyphenolic compounds present in green tea have offered substantial benefits to the prevention of viral infections, cardiovascular diseases, anti-aging, anti-diabetic, and many other health-beneficial effects [20] . 

Coronavirus is the predominant cause of mortality and morbidity; its pathogenicity and higher transmission rate are vital actions for continuously increasing confirmed cases [23] . Coronaviruses contain four main structural proteins like spike (S), membrane (M), envelope (E), and nucleocapsid (N) proteins. Contemporary publications have supported that the interconnection between induction of essential viral enzymes and proteins are essential for the increased incidence of COVID-19 [24] . Due to steadily rising mortality, COVID-19

remains the most commonly seen type of pandemic disease type of pneumonia and could cause high deaths, extremely difficult to control. The integral membrane envelope protein of coronavirus as versatile bioactive agents in assembling virions of the viral envelope characterized by high levels of pathogenesis [25] . Surprisingly, the spike (S) protein of SARS-CoV-2 consisting of two heptad repeat regions with crucial functions in the attachment and fusion with the cell membrane by binding to the host receptor angiotensinconverting enzyme 2; establishing a framework for the development and maintenance of virulence capacity [27, 28] . A detailed understanding of the subfamily coronavirinae J o u r n a l P r e -p r o o f consisting of four genus groups are alpha, beta, gamma, delta coronaviruses, and SARS-CoV belongs to beta-coronavirus, is required towards the outbreaks of corona pandemic ( Figure 1 ).

Taken together, the spike, envelope, membrane, and nucleocapsid proteins of coronavirus are causative factors for the viral entry, packing of viral particles, and infection in humans have successfully been proven ( Figure 2 ).

Structure of coronavirus [26] .

Current reports recognized that the envelope is made up of membrane (M) and

hemagglutinin-esterase (HE) spike (S) proteins. The S protein is an essential regulator that indicated excellent correlation with immune defense against the coronavirus leading to alteration and attenuation of functions of the immune system [29] . Remarkably, coronavirus spike protein acts as a class I viral fusion protein and may play an important role in viral entry within host cells [30] . Novel evidence underlined that the N-protein and M protein are in humans [33] . The papain-like protease could increase the pathogenic ability of coronavirus give rise to the spread of COVID-19 [34] .

J o u r n a l P r e -p r o o f

The research articles of the published literature were researched and discussed the role of chloroquine, hydroxychloroquine, green tea catechins, convalescent plasma therapy, and covaxin using such databases as PubMed and PubMed Central could be beneficial therapy.

The computational analysis made it possible to elucidate the structure-activity relationship of X-ray crystal structures of HKU4-CoV 3CLpro and SARS-CoV-2main protease in complex with inhibitors ECG, EGCG, chloroquine, and hydroxychloroquine. The X-ray crystallographic structure of protein molecules HKU4-CoV 3CLpro (PDB id 4YOG) and SARS-CoV-2 main protease (PDB id 7CAM) retrieved from Protein Data Bank (PDB).

The 3D structures of the lead molecules have been recovered in the PubChem database.

Molecular docking with HKU4-CoV 3CLpro against lead molecules was represented using Autogrid in PyRx tool to know the Best Binding pocket for each ligand molecule and docking results were elucidated [35] . Autodock uses the Lamarckian genetic algorithm [36] . The protein-ligand interaction was explained by utilizing PyMOL, the bond length bond angle, the key amino acid close to the ligand. The interaction figures were extracted from the PyMOL viewer [37] .

The primary effects of novel antiviral drugs, covaxin, and antiviral activity of green This review is beneficial to the scientific community and the general public due to the strong antiviral activity of chloroquine, hydroxychloroquine, green tea consumption, administration of convalescent plasma, and covaxin against COVID-19 infection. hazard has finally become accepted [39, 40] . The functional roles of vaccines holding the potential to be used in the treatment of COVID-19 remain unclear [41] . There is an urgent need to identify convalescent plasma therapy (CPT) as liable for protection that actively provides therapeutic effects against corona viral infection [42] . Passive immunization may be sufficient to drive functionally significant improvements in immune defense of humans [43] .

Convalescent plasma contains protective antibodies is helpful for the marked attenuation or eradication of corona infection by providing adaptive immunity [44, 45] . The convalescent plasma transfusion played a good safety record for recovery from COVID-19 and identified a link that assists in the control of the mortality of [46, 47] . To reduce pandemic COVID-19 viral infection, guidance is necessary to improve understanding of the complex interactions between direct blood centers and plasma from COVID-19-convalescent donors [48] . There is an urgent need to identify that convalescent plasma could be a therapeutic strategy for decreasing coronavirus infection [49] . The administration of convalescent plasma containing neutralizing antibodies improved the efficacy of antiviral therapy [50] .

The mortality, and recovery rates throughout the world [52, 53] . Hydroxychloroquine in combination with azithromycin (AZ) treatment was reported to be effective against COVID-19 [54] . Administration of the HCQ+AZ combination before COVID-19 complications occur is safe and associated with a very low fatality rate in patients [55] . Indian Council of Medical

Research constitutes National Task Force for COVID-19 recommended the use of hydroxychloroquine for preventive treatment of healthcare workers and individuals in close contact with coronavirus patients [56] .

There is an urgent need to identify that chloroquine and hydroxychloroquine have been designated to treat coronavirus disease 2019 and never possible to eradicate the prevention and occurrence of COVID-19 infection [57] . Current evidence has shown that HCQ and CQ may provide similar parallel broad-spectrum antiviral effects [3] . Likewise, allied effects of hydroxychloroquine and azithromycin showed a more powerful antiviral effect, and promising emergent research used as a desperate attempt results in the significantly low rate of virus load in COVID-19 patients [58] . Further, chloroquine binds to the virus cellular surface receptor and interferes with packing of viral particles leads to the attenuation of severe progression of COVID-19 [59] . National Health Commission of the People's Republic of China recommended that chloroquine phosphate may confer for the prevention and treatment of pneumonia caused by COVID-19 [60] .

Earlier reports have illustrated that the role of chloroquine and hydroxychloroquine in the retardation of endosome maturation leads to inhibition of transport of SARS-COV-2

virions [61] . The widespread use of CQ/HCQ during the 1st wave of COVID-19 was recommended by the National Health Commission, China, effective for the management of COVID-19. Current data from well-designed randomized controlled trials showed no evidence of benefit from CQ/HCQ supplementation for the prophylaxis against SARS-CoV-2 [62] . Hydroxychloroquine is essential for the early therapy of COVID-19, but there was no benefit associated with HCQ alone or in combination with azithromycin [63] .

Green tea may be possible strategies to reduce COVID-19 and has shown promising efficacy considered to be high [64] . The 3-galloyl and 5'-OH group of catechin derivatives J o u r n a l P r e -p r o o f revealed antiviral activities may serve as a therapeutic target against COVID-19, which represents a substantial public health threat [65] . EGCG exhibits multi-functional effects of antiviral, antitumorigenic, anti-inflammatory, antioxidative, and antiproliferative properties.

The epigallocatechin-3-gallate had a positive protrusive antiviral activity resulting in the limitation of COVID-19 infection [66] . The nutritional intake of green tea consists mainly of catechin polyphenols that can adapt to become more important in the inhibition of SARS CoV-2 Mpro protease and might be a better reference target for anti-COVID-19 drug development [67] . COVID-19 is a worldwide public health concern with high rates of outbreak and mortality. The EGCG has the potential to result in the improvement of reduced risk of corona infection through the inhibition of SARS-CoV-2 3CL-protease [68, 66] . The contribution of EGCG is a master regulator to counteract hyper-inflammation growing in COVID-19, which has a high prevalence and wide distribution [69] .

The significant role of M pro enzyme in the progressive pathogenesis of coronavirus and inhibition of this enzyme activity would block viral replication has been shown to be efficacious [70] . The 3C-like protease (3CL (pro)) enzyme is likely to emerge and help in SARS-CoV replication. Quercetin, epigallocatechin gallate, and gallocatechin gallate (GCG) make these attractive candidates and could serve as a better therapeutic approach toward inhibition of 3C-like protease [71] . The earlier surveys suggested that coronaviruses have evolved viral proteins are critical for preserving virulence results in the death of human patients likely to have been caused by acute respiratory distress syndrome (ARDS) [72] .

Numerous observations concur that the genome sequences of 2019-nCoV share a genetic sequence of 89% identical to bat SARS-like-CoVZXC21 and 82% identical to human SARS-CoV. Previously, differential outcomes have been used to identify that coronavirus was associated with both upper and lower respiratory tract infections [73] .

Consistent with findings from prior observations proposed that SARS-CoV-2 exhibits much higher capacity of membrane fusion, which is an important target for prophylactics that can prevent, and stop the spread of 2019-nCoV [74] . Recent analysis were performed to assess the malnourished, persons with weak immune system, diabetic, cardiac, and hypertensive individuals may be more susceptible to SARS-CoV-2 infection [75] .

Enhancement of the nuclear localization signals is widely present in the nucleocapsid and spike glycoprotein to be associated with a high case fatality rate [76] . Research evidence revealed that the active site region constitutes the aromatic amino acids His 41, His166, His175, Tyr54, and Phe143. Apparently, ligands' aromatic rings stacking against these aromatic residues in the binding pocket is likely to lead to a high binding affinity [77] . 

Fareeda Begum-wrote the manuscript; Swarna Latha-designed and supervised the study;

Anu Thomas-collected and analyzed the data; Chandra Mohan-Data curation; Rajashekar

Chikati-Software and editing; Sandeep-Methodology; Narendra Maddu-supervised the organization and editing of the manuscript.

No funding received

Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2): An Update

The history and epidemiology of Middle East respiratory syndrome corona virus

Discovery of a novel corona virus associated with the recent pneumonia outbreak in humans and its potential bat origin

Learning from the past: Possible urgent prevention and treatment options for severe acute respiratory infections caused by 2019-nCoV

WHO declares COVID-19 a pandemic

Molecular biology of coronaviruses: current knowledge

Novel 2019 coronavirus: Genome structure, clinical trials, and outstanding questions

Structure, function, and evolution of corona virus proteins

Detecting the emergence of novel, zoonotic viruses pathogenic to humans

Human coronaviruses: insights into environmental resistance and its influence on the development of new antiseptic strategies

Recent discovery and development of inhibitors targeting corona viruses

Genotype and phenotype of COVID-19: Their roles in pathogenesis

Recommendation for empiric use of hydroxychloroquine for prophylaxis of SARS-Co-2 infection

Coronavirus vaccine development: from SARS and MERS to COVID-19

Hydroxychloroquine and mortality in COVID-19 patients: a systematic review and a meta-analysis of observational studies and randomized controlled trials

Treatment of Coronavirus Disease 2019 (COVID-19) Patients with Convalescent Plasma

Coronaviruses from pheasants (Phasianus colchicus) are genetically closely related to coronaviruses of domestic fowl (infectious bronchitis virus) and turkeys

From SARS coronavirus to novel animal and human coronaviruses

Polymerases of corona viruses: Structure, function, and inhibitors. Viral Polymerases

Tea and health: studies in humans

A review of the antiviral role of green tea catechins

Green tea catechins: Their use in treating and preventing infectious diseases

Coronavirus Disease 2019-COVID-19

Coronaviruses: an overview of their replication and pathogenesis

Coronavirus envelope protein: current knowledge

The pathophysiology, diagnosis and treatment of corona virus disease 2019 (COVID-19)

Structural characterization of the SARS-coronavirus spike S fusion protein core

A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2

Access Science, McGraw-Hill Education

The coronavirus spike protein is a class I virus fusion protein: structural and functional characterization of the fusion core complex

Molecular basis of pathogenesis of coronaviruses: A comparative genomics approach to planetary health to prevent zoonotic outbreaks in the 21st Century

Cell entry mechanisms of SARS-CoV-2

Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods

Papain-like protease regulates SARS-CoV-2 viral spread and innate immunity

In silico evaluation of Benzo (f) chromen-3-one as a potential inhibitor of NF-κB: A key regulatory molecule in inflammationmediated pathogenesis of diabetes, Alzheimer's, and cancer

A Semiempirical free energy force field with charge-based desolvation

The PyMOL Molecular Graphics System

Effect of vaccination with a SARS-CoV-2 vaccine, coronavirus testing and application of the Corona-Warn-App

Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected

Convalescent plasma as a potential therapy for COVID-19

Convalescent plasma: possible therapy for novel coronavirus disease 2019

Convalescent plasma: A potential life-saving therapy for coronavirus disease 2019 (COVID-19)

The role of passive immunization in the age of SARS-CoV-2: an update

Effectiveness of convalescent plasma therapy in severe COVID-19 patients

Convalescent plasma therapy: a promising coronavirus disease 2019 treatment strategy

Convalescent plasma treatment of severe COVID-19: a propensity score-matched control study

Convalescent plasma transfusion for the treatment of COVID-19:Systematic review

Convalescent plasma to treat COVID-19: Possibilities and challenges

Convalescent plasma transfusion a promising therapy for coronavirus diseases 2019 (COVID-19): current updates

Treatment of 5 critically ill patients with COVID-19 with convalescent plasma

Treatment for COVID-19: An overview

Naming the corona virus disease (COVID-19) and the virus that causes it

Issues for conducting meta-analyses in COVID-19. Commentary on Prevalence and severity of corona virus disease 2019 (COVID-19): A systematic review and meta-analysis

Macrolide treatment for COVID-19: Will this be the way forward

Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France

Business Today; Lower Parel, Mumbai: Coronavirus outbreak: ICMR recommends the use of hydroxy-chloroquine for critical COVID-19 cases

Update on use of chloroquine/hydroxychloroquine to treat coronavirus disease 2019 (COVID-19)

Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an openlabel non-randomized clinical trial

New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19?

Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies

Chloroquine and COVID-19 -a potential game changer?

Chloroquine and hydroxychloroquine for the prevention and treatment of COVID-19: A Fiction, Hope or Hype? An updated review

An intent-to-treat analysis of hydroxychloroquine, with or without azithromycin, and COVID-19 outcomes amongst hospitalized US Veterans

Anti-inflammatory action of green tea

Antiviral mechanism of action of epigallocatechin-3-O-gallate and its fatty acid esters

Antiviral activity of green tea and black tea polyphenols in prophylaxis and treatment of COVID-19: A review

Evaluation of green tea polyphenols as novel corona virus (SARS CoV-2) main protease (Mpro) inhibitors -an in silico docking and molecular dynamics simulation study

EGCG, a green tea polyphenol, inhibits human coronavirus replication in vitro

Protective effect of Epigallocatechin-3-Gallate (EGCG) in diseases with uncontrolled immune activation: Could such a scenario be helpful to counteract COVID-19?

Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors

Flavonoidmediated inhibition of SARS coronavirus 3C-like protease expressed in Pichia pastoris

Coronavirus virulence genes with main focus on SARS-CoV envelope gene

Pathogenicity and transmissibility of 2019-nCoV-A quick overview and comparison with other emerging viruses

Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion

The malnutritional status of the host as a virulence factor for new coronavirus SARS-CoV-2

Genomic determinants of pathogenicity in SARS-CoV-2 and other human coronaviruses

Computational modeling of the bat HKU4 coronavirus 3CL pro inhibitors as a tool for the development of antivirals against the emerging Middle East respiratory syndrome (MERS) coronavirus

Structural basis for the inhibition of SARS-CoV-2 main protease by antineoplastic drug carmofur

No other potential conflicts of interest are reported.